Translational utility of experimental autoimmune encephalomyelitis: recent developments

References

• SadovnickADBairdPAWardRHMultiple sclerosis: updated risks for relativesAm J Med Genet19882935335413376997
   PubMed Web of Science ®Google Scholar
• O’GormanCLinRStankovichJBroadleySAModelling genetic susceptibility to multiple sclerosis with family dataNeuroepidemiology201340111223075677
   PubMed Web of Science ®Google Scholar
• EbersGCBulmanDESadovnickADA population-based study of multiple sclerosis in twinsN Engl J Med198631526163816423785335
   PubMed Web of Science ®Google Scholar
• JersildCSvejgaardAFogTHL-A antigens and multiple sclerosisLancet197217762124012414113225
   PubMed Web of Science ®Google Scholar
• International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2SawcerSGenetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosisNature2011476735921421921833088
   PubMed Web of Science ®Google Scholar
• OksenbergJRBarcellosLFCreeBAMapping multiple sclerosis susceptibility to the HLA-DR locus in African AmericansAm J Hum Genet200474116016714669136
   PubMed Web of Science ®Google Scholar
• International Multiple Sclerosis Genetics ConsortiumHaflerDACompstonARisk alleles for multiple sclerosis identified by a genomewide studyN Engl J Med2007357985186217660530
   PubMed Web of Science ®Google Scholar
• Australia, New Zealand Multiple Sclerosis Genetics Consortium (ANZgene)Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20Nat Genet200941782482819525955
   PubMed Web of Science ®Google Scholar
• International Multiple Sclerosis Genetics ConsortiumBeechamAHPatsopoulosNAAnalysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosisNat Genet201345111353136024076602
   PubMed Web of Science ®Google Scholar
• PatsopoulosNABarcellosLFHintzenRQFine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effectsPLoS Genet2013911e100392624278027
   PubMed Web of Science ®Google Scholar
• CouturierNBucciarelliFNurtdinovRNTyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibilityBrain2011134Pt 369370321354972
   PubMed Web of Science ®Google Scholar
• GregoryAPDendrouCAAttfieldKETNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosisNature2012488741250851122801493
   PubMed Web of Science ®Google Scholar
• HartmannFJKhademiMAramJMultiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cellsNat Commun20145505625278028
   PubMed Web of Science ®Google Scholar
• RobinsonAPHarpCTNoronhaAMillerSDThe experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatmentHandb Clin Neurol201412217318924507518
   PubMedGoogle Scholar
• Ben-NunAKaushanskyNKawakamiNFrom classic to spontaneous and humanized models of multiple sclerosis: impact on understanding pathogenesis and drug developmentJ Autoimmun201454335025175979
   PubMed Web of Science ®Google Scholar
• SharpeAHFreemanGJThe B7-CD28 superfamilyNat Rev Immunol20022211612611910893
   PubMed Web of Science ®Google Scholar
• ChangTTJabsCSobelRAKuchrooVKSharpeAHStudies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encepha-lomyelitisJ Exp Med1999190573374010477557
   PubMed Web of Science ®Google Scholar
• PerrinPJJuneCHMaldonadoJHRattsRBRackeMKBlockade of CD28 during in vitro activation of encephalitogenic T cells or after disease onset ameliorates experimental autoimmune encephalomyelitisJ Immunol199916331704171010415078
   PubMed Web of Science ®Google Scholar
• CrossAHSanMKeelingRMKarrRWCTLA-4-Fc treatment of ongoing EAE improves recovery, but has no effect upon relapse rate. Implications for the mechanisms involved in disease perpetuationJ Neuroimmunol199996214414710337912
   PubMed Web of Science ®Google Scholar
• CroxfordJLO’NeillJKAliRRLocal gene therapy with CTLA4-immunoglobulin fusion protein in experimental allergic encephalomyelitisEur J Immunol19982812390439169862327
   PubMed Web of Science ®Google Scholar
• ChangTTSobelRAWeiTRansohoffRMKuchrooVKSharpeAHRecovery from EAE is associated with decreased survival of encephalitogenic T cells in the CNS of B7-1/B7-2-deficient miceEur J Immunol20033372022203212884869
   PubMed Web of Science ®Google Scholar
• PeferoenLAVogelDYUmmenthumKActivation status of human microglia is dependent on lesion formation stage and remyelination in multiple sclerosisJ Neuropathol Exp Neurol2015741486325470347
   PubMed Web of Science ®Google Scholar
• CodarriLGreterMBecherBCommunication between pathogenic T cells and myeloid cells in neuroinflammatory diseaseTrends Immunol201334311411923116549
   PubMed Web of Science ®Google Scholar
• VainchteinIDVinetJBrouwerNIn acute experimental autoimmune encephalomyelitis, infiltrating macrophages are immune activated, whereas microglia remain immune suppressedGlia201462101724173524953459
   PubMed Web of Science ®Google Scholar
• HildebrandJMYiZBuchtaCMPoovasseryJStunzLLBishopGARoles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functionsImmunol Rev20112441557422017431
   PubMed Web of Science ®Google Scholar
• BishopGAXiePMultiple roles of TRAF3 signaling in lymphocyte functionImmunol Res2007391–3223217917053
   PubMed Web of Science ®Google Scholar
• ZhuSPanWShiPModulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signalingJ Exp Med2010207122647266221078888
   PubMed Web of Science ®Google Scholar
• XiaoYJinJChangMPeli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradationNat Med201319559560223603814
   PubMed Web of Science ®Google Scholar
• ManaPLinaresDSilvaDGLIGHT (TNFSF14/CD258) is a decisive factor for recovery from experimental autoimmune encephalomyelitisJ Immunol2013191115416323720813
   PubMed Web of Science ®Google Scholar
• WestLCCresswellPExpanding roles for GILT in immunityCurr Opin Immunol201325110310823246037
   PubMed Web of Science ®Google Scholar
• BergmanCMMartaCBMaricMPfeifferSECresswellPRuddleNHA switch in pathogenic mechanism in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in IFN-γ-inducible lysosomal thiol reductase-free miceJ Immunol2012188126001600922586035
   PubMed Web of Science ®Google Scholar
• BurrowsGGMeza-RomeroRHuanJGilt required for RTL550-CYS-MOG to treat experimental autoimmune encephalomyelitisMetab Brain Dis201227214314922392628
   PubMed Web of Science ®Google Scholar
• ChitnisTKhourySJRole of costimulatory pathways in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitisJ Allergy Clin Immunol2003112583714610467
   PubMed Web of Science ®Google Scholar
• IssazadehSNavikasVSchaubMKinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivoJ Immunol19981613110411129686568
   PubMed Web of Science ®Google Scholar
• LamanJDMaassenCBSchellekensMMTherapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptideMult Scler1998431471539762665
   PubMed Web of Science ®Google Scholar
• BecherBDurellBGMigaAVHickeyWFThe clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous systemJ Exp Med2001193896797411304557
   PubMed Web of Science ®Google Scholar
• IezziGSondereggerIAmpenbergerFSchmitzNMarslandBJKopfMCD40-CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cellsProc Natl Acad Sci U S A2009106387688119136631
   PubMed Web of Science ®Google Scholar
• Perona-WrightGJenkinsSJO’ConnorRAA pivotal role for CD40-mediated IL-6 production by dendritic cells during IL-17 induction in vivoJ Immunol200918252808281519234175
   PubMed Web of Science ®Google Scholar
• HochwellerKAndertonSMSystemic administration of antigen-loaded CD40-deficient dendritic cells mimics soluble antigen administrationEur J Immunol200434499099815048709
   PubMed Web of Science ®Google Scholar
• KalantariTKarimiMHCiricBYanYRostamiAKamali-SarvestaniETolerogenic dendritic cells produced by lentiviral-mediated CD40-and interleukin-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing T helper type 17 cellsClin Exp Immunol2014176218018924387596
   PubMed Web of Science ®Google Scholar
• GrewalISFoellmerHGGrewalKDRequirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitisScience19962735283186418678791592
   PubMed Web of Science ®Google Scholar
• GerritseKLamanJDNoelleRJCD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosisProc Natl Acad Sci U S A1996936249925048637903
   PubMed Web of Science ®Google Scholar
• HowardLMMigaAJVanderlugtCLMechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosisJ Clin Invest199910322812909916140
   PubMed Web of Science ®Google Scholar
• HowardLMMillerSDAutoimmune intervention by CD154 blockade prevents T cell retention and effector function in the target organJ Immunol200116631547155311160195
   PubMed Web of Science ®Google Scholar
• NagelkerkenLHaspelsIvan RijsWFcR interactions do not play a major role in inhibition of experimental autoimmune encephalomyelitis by anti-CD154 monoclonal antibodiesJ Immunol2004173299399915240687
   PubMed Web of Science ®Google Scholar
• HowardLMDal CantoMCMillerSDTransient anti-CD154-mediated immunotherapy of ongoing relapsing experimental autoimmune encephalomyelitis induces long-term inhibition of disease relapsesJ Neuroimmunol20021291–2586512161021
   PubMed Web of Science ®Google Scholar
• HowardLMNevilleKLHaynesLMDal CantoMCMillerSDCD154 blockade results in transient reduction in Theiler’s murine encephalomyelitis virus-induced demyelinating diseaseJ Virol20037732247225012525660
   PubMed Web of Science ®Google Scholar
• DrescherKMZoeckleinLJPavelkoKDRivera-QuinonesCHollenbaughDRodriguezMCD40L is critical for protection from demyelinating disease and development of spontaneous remyelination in a mouse model of multiple sclerosisBrain Pathol200010111510668891
   PubMed Web of Science ®Google Scholar
• SamoilovaEBHortonJLZhangHChenYCD40L blockade prevents autoimmune encephalomyelitis and hampers TH1 but not TH2 pathway of T cell differentiationJ Mol Med19977586036089297628
   PubMed Web of Science ®Google Scholar
• DuCBrightJJSriramSInhibition of CD40 signaling pathway by tyrphostin A1 reduces secretion of IL-12 in macrophage, Th1 cell development and experimental allergic encephalomyelitis in SJL/J miceJ Neuroimmunol20011141–2697911240017
   PubMed Web of Science ®Google Scholar
• DingQSiXLiuDTargeting and liposomal drug delivery to CD40L expressing T cells for treatment of autoimmune diseasesJ Control Release2015207869225839125
   PubMed Web of Science ®Google Scholar
• SchaubMIssazadehSStadlbauerTHWCostimulatory signal blockade in murine relapsing experimental autoimmune encephalomyelitisJ Neuroimmunol199996215816610337914
   PubMed Web of Science ®Google Scholar
• LamanJDt HartBABrokHProtection of marmoset monkeys against EAE by treatment with a murine antibody blocking CD40 (mu5D12)Eur J Immunol20023282218222812209634
   PubMed Web of Science ®Google Scholar
• BoonLBrokHPMBauerJPrevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) using a chimeric antagonist monoclonal antibody against human CD40 is associated with altered B cell responsesJ Immunol200116752942294911509643
   PubMed Web of Science ®Google Scholar
• BoonLLamanJDOrtiz-BuijsseAPreclinical assessment of anti-CD40 Mab 5D12 in cynomolgus monkeysToxicology20021741536511972992
   PubMed Web of Science ®Google Scholar
• HongGUKimNGJeoungDRoJYAnti-CD40 Ab- or 8-oxo-dG-enhanced Treg cells reduce development of experimental autoimmune encephalomyelitis via down-regulating migration and activation of mast cellsJ Neuroimmunol20132601–2607323622820
   PubMed Web of Science ®Google Scholar
• KimDYJeoungDRoJYSignaling pathways in the activation of mast cells cocultured with astrocytes and colocalization of both cells in experimental allergic encephalomyelitisJ Immunol2010185127328320511559
   PubMed Web of Science ®Google Scholar
• t HartBABlezerELBrokHPTreatment with chimeric anti-human CD40 antibody suppresses MRI-detectable inflammation and enlargement of pre-existing brain lesions in common marmosets affected by MOG-induced EAEJ Neuroimmunol20051631–2313915885306
   PubMed Web of Science ®Google Scholar
• IchikawaHTWilliamsLPActivation of APCs through CD40 or Toll-like receptor 9 overcomes tolerance and precipitates autoimmune diseaseJ Immunol200216952781278712193753
   PubMed Web of Science ®Google Scholar
• ZhangJLiuQLangdonWYCbl-b: roles in T cell tolerance, proallergic T cell development, and cancer immunityInflamm Cell signal201414e14626082933
   PubMedGoogle Scholar
• HaradaYHaradaYEllyCTranscription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cellsJ Exp Med201020771381139120439537
   PubMed Web of Science ®Google Scholar
• ChiangYJKoleHKBrownKCbl-b regulates the CD28 dependence of T-cell activationNature2000403676621622010646609
   PubMed Web of Science ®Google Scholar
• FujiwaraMAnstadtEJKhannaKMClarkRBCbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720Clin Immunol2015158110311325829233
   PubMed Web of Science ®Google Scholar
• ChitnisTNajafianNBenouCEffect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitisJ Clin Invest2001108573974711544280
   PubMed Web of Science ®Google Scholar
• Lovett-RackeAEYangYRackeMKTh1 versus Th17: are T cell cytokines relevant in multiple sclerosis?Biochim Biophys Acta20111812224625120600875
   PubMed Web of Science ®Google Scholar
• DuhenRGlatignySArbelaezCABlairTCOukkaMBettelliECutting edge: the pathogenicity of IFN-gamma-producing Th17 cells is independent of T-betJ Immunol201319094478448223543757
   PubMed Web of Science ®Google Scholar
• WeiLVahediGSunHWDiscrete roles of STAT4 and STAT6 transcription factors in tuning epigenetic modifications and transcription during T helper cell differentiationImmunity201032684085120620946
   PubMed Web of Science ®Google Scholar
• McWilliamsILRajbhandariRNozellSBenvenisteEHarringtonLESTAT4 controls GM-CSF production by both Th1 and Th17 cells during EAEJ Neuroinflamm201512128
   PubMed Web of Science ®Google Scholar
• CodarriLGyulvesziGTosevskiVRORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammationNat Immunol201112656056721516112
   PubMed Web of Science ®Google Scholar
• El-BehiMCiricBDaiHThe encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSFNat Immunol201112656857521516111
   PubMed Web of Science ®Google Scholar
• MoCChearwaeWO’MalleyJTStat4 isoforms differentially regulate inflammation and demyelination in experimental allergic encephalomyelitisJ Immunol200818185681569018832727
   PubMed Web of Science ®Google Scholar
• BecherBDurellBGNoelleRJExperimental autoimmune encephalitis and inflammation in the absence of interleukin-12J Clin Invest2002110449349712189243
   PubMed Web of Science ®Google Scholar
• GranBZhangGXYuSIL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelinationJ Immunol2002169127104711012471147
   PubMed Web of Science ®Google Scholar
• CuaDJSherlockJChenYInterleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature2003421692474474812610626
   PubMed Web of Science ®Google Scholar
• BecherBDurellBGNoelleRJIL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitisJ Clin Invest200311281186119114561703
   PubMed Web of Science ®Google Scholar
• MondalSRoyAPahanKFunctional blocking monoclonal antibodies against IL-12p40 homodimer inhibit adoptive transfer of experimental allergic encephalomyelitisJ Immunol200918285013502319342681
   PubMed Web of Science ®Google Scholar
• WallineCCKanakasabaiSBrightJJIL-7Ralpha confers susceptibility to experimental autoimmune encephalomyelitisGenes Immun201112111420861865
   PubMed Web of Science ®Google Scholar
• LeeLFAxtellRTuGHIL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-beta in multiple sclerosisSci Transl Med201139393ra68
   PubMed Web of Science ®Google Scholar
• AshbaughJJBrambillaRKarmallySACabelloCMalekTRBetheaJRIL7Ralpha contributes to experimental autoimmune encephalomyelitis through altered T cell responses and nonhematopoi-etic cell lineagesJ Immunol201319094525453423530149
   PubMed Web of Science ®Google Scholar
• KreftKLVerbraakEWierenga-WolfAFDecreased systemic IL-7 and soluble IL-7Ralpha in multiple sclerosis patientsGenes Immun201213758759222914435
   PubMed Web of Science ®Google Scholar
• LundstromWHighfillSWalshSTSoluble IL7Ralpha potentiates IL-7 bioactivity and promotes autoimmunityProc Natl Acad Sci U S A201311019E1761E177023610432
   PubMed Web of Science ®Google Scholar
• WillerfordDMChenJFerryJADavidsonLMaAAltFWInterleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartmentImmunity1995345215307584142
   PubMed Web of Science ®Google Scholar
• FurtadoGCCurotto de LafailleMAKutchukhidzeNLafailleJJInterleukin 2 signaling is required for CD4(+) regulatory T cell functionJ Exp Med2002196685185712235217
   PubMed Web of Science ®Google Scholar
• WebsterKEWaltersSKohlerREIn vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppressionJ Exp Med2009206475176019332874
   PubMed Web of Science ®Google Scholar
• HaoJCampagnoloDLiuRInterleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammationAnn Neurol201169472173421425186
   PubMed Web of Science ®Google Scholar
• MaierLMAndersonDESeversonCASoluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responsesJ Immunol200918231541154719155502
   PubMed Web of Science ®Google Scholar
• RussellSEMooreACFallonPGWalshPTSoluble IL-2Ralpha (sCD25) exacerbates autoimmunity and enhances the development of Th17 responses in micePloS One2012710e4774823077668
   PubMed Web of Science ®Google Scholar
• O’SheaJJPlengeRJAK and STAT signaling molecules in immunoregulation and immune-mediated diseaseImmunity201236454255022520847
   PubMed Web of Science ®Google Scholar
• OyamadaAIkebeHItsumiMTyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitisJ Immunol2009183117539754619917699
   PubMed Web of Science ®Google Scholar
• SpachKMNoubadeRMcElvanyBHickeyWFBlankenhornEPTeuscherCA single nucleotide polymorphism in Tyk2 controls susceptibility to experimental allergic encephalomyelitisJ Immunol2009182127776778319494301
   PubMed Web of Science ®Google Scholar
• LiuXLeeYSYuCREgwuaguCELoss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseasesJ Immunol200818096070607618424728
   PubMed Web of Science ®Google Scholar
• MarisCHHousseauFYuHPardollDMCutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunityJ Immunol200717974313431717878325
   PubMed Web of Science ®Google Scholar
• MuthianGRaikwarHPJohnsonCCOX-2 inhibitors modulate IL-12 signaling through JAK-STAT pathway leading to Th1 response in experimental allergic encephalomyelitisJ Clin Immunol2006261738516418805
   PubMed Web of Science ®Google Scholar
• MuthianGRaikwarHPRajasinghJBrightJJ1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitisJ Neurosci Res20068371299130916547967
   PubMed Web of Science ®Google Scholar
• ChenCLiuXWanBZhangJZRegulatory properties of copo-lymer I in Th17 differentiation by altering STAT3 phosphorylationJ Immunol2009183124625319542436
   PubMed Web of Science ®Google Scholar
• NathNGiriSPrasadRSinghAKSinghIPotential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapyJ Immunol200417221273128614707106
   PubMed Web of Science ®Google Scholar
• LiuYHoldbrooksATDe SarnoPTherapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitisJ Immunol20141921597224323580
   PubMed Web of Science ®Google Scholar
• MuthianGBrightJJQuercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyteJ Clin Immunol200424554255215359113
   PubMed Web of Science ®Google Scholar
• NatarajanCBrightJJCurcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytesJ Immunol2002168126506651312055272
   PubMed Web of Science ®Google Scholar
• XieLLiXKFuneshima-FujiNAmelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 productionInt Immunopharmacol20099557558119539560
   PubMed Web of Science ®Google Scholar
• QinXGuoBTWanBFangLLuLWuLRegulation of Th1 and Th17 cell differentiation and amelioration of experimental autoimmune encephalomyelitis by natural product compound berberineJ Immunol2010179743134317
   Google Scholar
• XueZGeZZhangKEmbelin suppresses dendritic cell functions and limits autoimmune encephalomyelitis through the TGF-β/β-catenin and STAT3 signaling pathwaysMol Neurobiol20144921087110124258405
   PubMed Web of Science ®Google Scholar
• YinLChenYQuZInvolvement of JAK/STAT signaling in the effect of cornel iridoid glycoside on experimental autoimmune encephalomyelitis amelioration in ratsJ Neuroimmunol20142741–2283725012120
   PubMed Web of Science ®Google Scholar
• JiaYJingJBaiYAmelioration of experimental autoimmune encephalomyelitis by plumbagin through down-regulation of JAK-STAT and NF-kappaB signaling pathwaysPloS One2011610e2700622066025
   PubMed Web of Science ®Google Scholar
• YoshimuraANakaTKuboMSOCS proteins, cytokine signalling and immune regulationNat Rev Immunol20077645446517525754
   PubMed Web of Science ®Google Scholar
• BakerBJAkhtarLNBenvenisteENSOCS1 and SOCS3 in the control of CNS immunityTrends Immunol200930839240019643666
   PubMed Web of Science ®Google Scholar
• QinHYehWIDe SarnoPSignal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammationProc Natl Acad Sci U S A2012109135004500922411837
   PubMed Web of Science ®Google Scholar
• LiuYHoldbrooksATMearesGPBuckleyJABenvenisteENQinHPreferential recruitment of neutrophils into the cerebellum and brainstem contributes to the atypical experimental autoimmune encephalomyelitis phenotypeJ Immunol2015195384185226085687
   PubMed Web of Science ®Google Scholar
• LiYChuNRostamiAZhangGXDendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivoJ Immunol200617731679168816849477
   PubMed Web of Science ®Google Scholar
• ZaheerSWuYBassettJYangBZaheerAGlia maturation factor regulation of STAT expression: a novel mechanism in experimental autoimmune encephalomyelitisNeurochem Res200732122123213117551829
   PubMed Web of Science ®Google Scholar
• ZhuEWangXZhengBmiR-20b suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis by targeting RORγt and STAT3J Immunol2014192125599560924842756
   PubMed Web of Science ®Google Scholar
• PanWZhuSDaiDMiR-125a targets effector programs to stabilize Treg-mediated immune homeostasisNat Commun20156709625963922
   PubMed Web of Science ®Google Scholar
• XieLChenJMcMickleAThe immunomodulator AS101 suppresses production of inflammatory cytokines and ameliorates the pathogenesis of experimental autoimmune encephalomyelitisJ Neuroimmunol20142731–2314124975323
   PubMed Web of Science ®Google Scholar
• Mc GuireCPrinzMBeyaertRvan LooGNuclear factor kappa B (NF-kappaB) in multiple sclerosis pathologyTrends Mol Med2013191060461324007818
   PubMed Web of Science ®Google Scholar
• HilliardBSamoilovaEBLiuTSRostamiAChenYExperimental autoimmune encephalomyelitis in NF-kappa B-deficient mice:roles of NF-kappa B in the activation and differentiation of autoreactive T cellsJ Immunol199916352937294310453042
   PubMed Web of Science ®Google Scholar
• O’DonnellSMHansbergerMWConnollyJLOrgan-specific roles for transcription factor NF-kappaB in reovirus-induced apoptosis and diseaseJ Clin Invest200511592341235016100570
   PubMed Web of Science ®Google Scholar
• SchneiderAMartin-VillalbaAWeihFVogelJWirthTSchwaningerMNF-kappaB is activated and promotes cell death in focal cerebral ischemiaNat Med19995555455910229233
   PubMed Web of Science ®Google Scholar
• ThomeMChartonJEPelzerCHailfingerSAntigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1Cold Spring Harb Perspect Biol201029a00300420685844
   PubMed Web of Science ®Google Scholar
• MolineroLLCubreAMora-SolanoCWangYAlegreMLT cell receptor/CARMA1/NF-kappaB signaling controls T-helper (Th) 17 differentiationProc Natl Acad Sci U S A201210945185291853423091043
   PubMed Web of Science ®Google Scholar
• BrustleABrennerDKnobbeCBThe NF-kappaB regulator MALT1 determines the encephalitogenic potential of Th17 cellsJ Clin Invest2012122124698470923114599
   PubMed Web of Science ®Google Scholar
• Mc GuireCWieghoferPEltonLParacaspase MALT1 deficiency protects mice from autoimmune-mediated demyelinationJ Immunol201319062896290323401595
   PubMed Web of Science ®Google Scholar
• JaworskiMMarslandBJGehrigJMalt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunityEMBO J201433232765278125319413
   PubMed Web of Science ®Google Scholar
• Mc GuireCEltonLWieghoferPPharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosisJ Neuroinflammation20141112425043939
   PubMed Web of Science ®Google Scholar
• KiharaYMatsushitaTKitaYTargeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosisProc Natl Acad Sci U S A200910651218072181219995978
   PubMed Web of Science ®Google Scholar
• EsakiYLiYSakataDDual roles of PGE2-EP4 signaling in mouse experimental autoimmune encephalomyelitisProc Natl Acad Sci U S A201010727122331223820566843
   PubMed Web of Science ®Google Scholar
• BoschXSaizARamos-CasalsMGroupBSMonoclonal antibody therapy-associated neurological disordersNat Rev Neurol20117316517221263460
   PubMed Web of Science ®Google Scholar
• van OostenBWBarkhofFTruyenLIncreased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2Neurology1996476153115348960740
   PubMed Web of Science ®Google Scholar
• TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis GroupNeurology199953345746510449104
   PubMed Web of Science ®Google Scholar
• OttoboniLFrohlichIYLeeMClinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locusNeurology201381221891189924174586
   PubMed Web of Science ®Google Scholar
• NomuraTAbeYKamadaHTherapeutic effect of PEGylated TNFR1-selective antagonistic mutant TNF in experimental autoimmune encephalomyelitis miceJ Control Release2011149181420036293
   PubMed Web of Science ®Google Scholar
• WilliamsSKMaierOFischerRAntibody-mediated inhibition of TNFR1 attenuates disease in a mouse model of multiple sclerosisPloS One201492e9011724587232
   PubMed Web of Science ®Google Scholar
• SuvannavejhGCLeeHOPadillaJDal CantoMCBarrettTAMillerSDDivergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35–55)-induced experimental autoimmune encephalomyelitisCell Immunol20002051243311078604
   PubMed Web of Science ®Google Scholar
• EugsterHPFreiKBachmannRBluethmannHLassmannHFontanaASeverity of symptoms and demyelination in MOG-induced EAE depends on TNFR1Eur J Immunol199929262663210064079
   PubMed Web of Science ®Google Scholar
• KassiotisGKolliasGUncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelinationJ Exp Med2001193442743411181695
   PubMed Web of Science ®Google Scholar
• FeldmanDKrishnanAVSwamiSGiovannucciEFeldmanBJThe role of vitamin D in reducing cancer risk and progressionNat Rev Cancer201414534235724705652
   PubMed Web of Science ®Google Scholar
• SpachKMHayesCEVitamin D3 confers protection from autoimmune encephalomyelitis only in female miceJ Immunol200517564119412616148162
   PubMed Web of Science ®Google Scholar
• PaintliaASPaintliaMKHollisBWSinghAKSinghIInterference with RhoA-ROCK signaling mechanism in autoreactive CD4+ T cells enhances the bioavailability of 1,25-dihydroxyvitamin D3 in experimental autoimmune encephalomyelitisAm J Pathol20121813993100622796435
   PubMed Web of Science ®Google Scholar
• FarhKKMarsonAZhuJGenetic and epigenetic fine mapping of causal autoimmune disease variantsNature2015518753933734325363779
   PubMed Web of Science ®Google Scholar
• ClaussnitzerMDankelSNKimKHFTO obesity variant circuitry and adipocyte browning in humansN Engl J Med2015373189590726287746
   PubMed Web of Science ®Google Scholar
• SanderJDJoungJKCRISPR-Cas systems for editing, regulating and targeting genomesNat Biotechnol4201432434735524584096
   PubMed Web of Science ®Google Scholar
• SellebjergFSorensenPSTherapeutic interference with leukocyte recirculation in multiple sclerosisEur J Neurol201522343444225582213
   PubMed Web of Science ®Google Scholar
• HuberMHeinkSGrotheHA Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activityEur J Immunol20093971716172519544308
   PubMed Web of Science ®Google Scholar
• FordeEADoganRNKarpusWJCCR4 contributes to the pathogenesis of experimental autoimmune encephalomyelitis by regulating inflammatory macrophage functionJ Neuroimmunol20112361–2172621575994
   PubMed Web of Science ®Google Scholar
• PoppensiekerKOtteDMSchurmannBCC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cellsProc Natl Acad Sci U S A2012109103897390222355103
   PubMed Web of Science ®Google Scholar
• SturnerKHBorgmeyerUSchulzeCPlessOMartinRA multiple sclerosis-associated variant of CBLB links genetic risk with type I IFN functionJ Immunol201419394439444725261476
   PubMed Web of Science ®Google Scholar
• AkkadDABellenbergBEsserSMultiple sclerosis risk loci correlate with cervical cord atrophy and may explain the course of disabilityNeurogenetics201516316116825620546
   PubMed Web of Science ®Google Scholar
• MaJWangRFangXDingYSunZCritical role of TCF-1 in repression of the IL-17 genePloS One201169e2476821935461
   PubMed Web of Science ®Google Scholar
• LaaksonenHGuerreiro-CacaisAOAdzemovicMZThe multiple sclerosis risk gene IL22RA2 contributes to a more severe murine autoimmune neuroinflammationGenes Immun201415745746525008863
   PubMed Web of Science ®Google Scholar
• LiuXHeFPangRInterleukin-17 (IL-17)-induced microRNA 873 (miR-873) contributes to the pathogenesis of experimental autoimmune encephalomyelitis by targeting A20 ubiquitin-editing enzymeJ Biological Chem2014289422897128986
   PubMed Web of Science ®Google Scholar
• WangXDeckertMXuanNTAstrocytic A20 ameliorates experimental autoimmune encephalomyelitis by inhibiting NF-kappaB- and STAT1-dependent chemokine production in astrocytesActa Neuropathol Epub2013929
   Web of Science ®Google Scholar
• TogniMSwansonKDReimannSRegulation of in vitro and in vivo immune functions by the cytosolic adaptor protein SKAP-HOMMol Cell Biol200525188052806316135797
   PubMed Web of Science ®Google Scholar
• BagaevaLVRaoPPowersJMSegalBMCXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitisJ Immunol2006176127676768516751415
   PubMed Web of Science ®Google Scholar
• KlimatchevaEPandinaTReillyCCXCL13 antibody for the treatment of autoimmune disordersBMC Immunol201516625879435
   PubMed Web of Science ®Google Scholar
• SchramlBUHildnerKIseWThe AP-1 transcription factor Batf controls T(H)17 differentiationNature2009460725340540919578362
   PubMed Web of Science ®Google Scholar
• MiaoTRaymondMBhullarPEarly growth response gene-2 controls IL-17 expression and Th17 differentiation by negatively regulating BatfJ Immunol20131901586523203924
   PubMed Web of Science ®Google Scholar
• YoshidaYYoshimiRYoshiiHThe transcription factor IRF8 activates integrin-mediated TGF-beta signaling and promotes neuroinflammationImmunity201440218719824485804
   PubMed Web of Science ®Google Scholar
• ChrabotBSKariukiSNZervouMIGenetic variation near IRF8 is associated with serologic and cytokine profiles in systemic lupus erythematosus and multiple sclerosisGenes Immun201314847147823965942
   PubMed Web of Science ®Google Scholar
• HowardLMOstrovidovSSmithCEDal CantoMCMillerSDNormal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitisJ Clin Invest2002109223324111805135
   PubMed Web of Science ®Google Scholar
• ChenSJWangYLKaoJHDecoy receptor 3 ameliorates experimental autoimmune encephalomyelitis by directly counteracting local inflammation and downregulating Th17 cellsMol Immunol2009472–356757419819554
   PubMed Web of Science ®Google Scholar
• SättlerMBDemmerIWilliamsSKEffects of interferon-beta-1a on neuronal survival under autoimmune inflammatory conditionsExp Neurol2006201117218116764858
   PubMed Web of Science ®Google Scholar